Similar articles for PMID: 22842346

Year	Number of Results
2005	2
2006	2
2007	2
2008	6
2009	6
2010	8
2011	12
2012	12
2013	10
2014	13
2015	6
2016	8
2017	4
2018	10
2019	5
2020	2
2021	2
2022	1
2024	0

1

Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.

Chiba S, Baghdadi M, Akiba H, Yoshiyama H, Kinoshita I, Dosaka-Akita H, Fujioka Y, Ohba Y, Gorman JV, Colgan JD, Hirashima M, Uede T, Takaoka A, Yagita H, Jinushi M. Chiba S, et al. Nat Immunol. 2012 Sep;13(9):832-42. doi: 10.1038/ni.2376. Epub 2012 Jul 29. Nat Immunol. 2012. PMID: 22842346 Free PMC article.

2

Tumor immunity times out: TIM-3 and HMGB1.

Tang D, Lotze MT. Tang D, et al. Nat Immunol. 2012 Sep;13(9):808-10. doi: 10.1038/ni.2396. Nat Immunol. 2012. PMID: 22910384 Free PMC article.

3

Taming dendritic cells with TIM-3: another immunosuppressive strategy used by tumors.

Patel J, Bozeman EN, Selvaraj P. Patel J, et al. Immunotherapy. 2012 Dec;4(12):1795-8. doi: 10.2217/imt.12.126. Immunotherapy. 2012. PMID: 23240746 Free PMC article.

4

Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk--a pivotal role of HMGB1.

Melki MT, Saïdi H, Dufour A, Olivo-Marin JC, Gougeon ML. Melki MT, et al. PLoS Pathog. 2010 Apr 15;6(4):e1000862. doi: 10.1371/journal.ppat.1000862. PLoS Pathog. 2010. PMID: 20419158 Free PMC article.

5

Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.

Nagahara K, Arikawa T, Oomizu S, Kontani K, Nobumoto A, Tateno H, Watanabe K, Niki T, Katoh S, Miyake M, Nagahata S, Hirabayashi J, Kuchroo VK, Yamauchi A, Hirashima M. Nagahara K, et al. J Immunol. 2008 Dec 1;181(11):7660-9. doi: 10.4049/jimmunol.181.11.7660. J Immunol. 2008. PMID: 19017954 Free PMC article.

6

HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses.

Yanai H, Ban T, Wang Z, Choi MK, Kawamura T, Negishi H, Nakasato M, Lu Y, Hangai S, Koshiba R, Savitsky D, Ronfani L, Akira S, Bianchi ME, Honda K, Tamura T, Kodama T, Taniguchi T. Yanai H, et al. Nature. 2009 Nov 5;462(7269):99-103. doi: 10.1038/nature08512. Nature. 2009. PMID: 19890330

7

Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination.

Desmet CJ, Ishii KJ. Desmet CJ, et al. Nat Rev Immunol. 2012 Jun 22;12(7):479-91. doi: 10.1038/nri3247. Nat Rev Immunol. 2012. PMID: 22728526 Review.

8

c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor.

Gujar R, Maurya N, Yadav V, Gupta M, Arora S, Khatri N, Sen P. Gujar R, et al. J Immunol. 2016 Sep 1;197(5):1650-62. doi: 10.4049/jimmunol.1600104. Epub 2016 Jul 20. J Immunol. 2016. PMID: 27439518

9

Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice.

Han J, Zhong J, Wei W, Wang Y, Huang Y, Yang P, Purohit S, Dong Z, Wang MH, She JX, Gong F, Stern DM, Wang CY. Han J, et al. Diabetes. 2008 Aug;57(8):2118-27. doi: 10.2337/db07-1499. Epub 2008 May 13. Diabetes. 2008. PMID: 18477810 Free PMC article.

10

Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer.

Chevalier MF, Bohner P, Pieraerts C, Lhermitte B, Gourmaud J, Nobile A, Rotman S, Cesson V, Martin V, Legris AS, Dartiguenave F, Gharbi D, De Leval L, Speiser DE, Nardelli-Haefliger D, Jichlinski P, Derré L. Chevalier MF, et al. Eur Urol. 2017 Jun;71(6):854-857. doi: 10.1016/j.eururo.2016.10.009. Epub 2016 Oct 27. Eur Urol. 2017. PMID: 28277277

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year